Title: Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain.
Journal: PloS one 20100101
1003710-01-7
1003709-96-3
1262419-96-4
1583-66-0
385-00-2
845885-90-7
15862-30-3 | 3-Bromo-5-nitropyridine | AA001QAI | MFCD04114216
159459-52-6 | 2H-1,4-Benzoxazin-3(4H)-one, 6-(1-aminoethyl)- | AA001QME | MFCD08444636
158930-18-8 | 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3S)- | AA001QXH | MFCD00930979
159635-39-9 | Spiro[chroman-2,4'-piperidin]-4-one, HCl | AA001R6J | MFCD04971902
159877-47-1 | Methyl (R)-N-boc-3-aminobutyrate | AA001REW | MFCD03788463
160194-29-6 | 3-Butyn-1-ol, 4-(triethylsilyl)- | AA001ROF | MFCD00190219
160657-08-9 | 6-Chloro-3-methoxypyrrolo[1,2-a]quinoxaline | AA001S0I | MFCD28050016
161344-85-0 | (4R,5R)-2-butyl-4-N,4-N,5-N,5-N-tetramethyl-1,3,2-dioxaborolane-4,5-dicarboxamide | AA001SB1 | MFCD04113606
162046-50-6 | (2-Amino-benzyl)-carbamic acid tert-butyl ester | AA001SLD | MFCD04071350
1623-14-9 | Phosphoric acid, monoethyl ester | AA001SWM | MFCD00045735